Edition:
United Kingdom

Jiangsu Hengrui Medicine Co Ltd (600276.SS)

600276.SS on Shanghai Stock Exchange

73.32CNY
6:59am GMT
Change (% chg)

¥0.85 (+1.17%)
Prev Close
¥72.47
Open
¥72.98
Day's High
¥74.88
Day's Low
¥72.43
Volume
9,661,952
Avg. Vol
13,356,390
52-wk High
¥78.75
52-wk Low
¥41.21

Select another date:

Mon, Jan 8 2018

BRIEF-TG Therapeutics, Jiangsu Hengrui Announce Agreement For BTK Inhibitor Program For Treatment Of Hematologic Malignancies

* TG THERAPEUTICS AND JIANGSU HENGRUI MEDICINE ANNOUNCE GLOBAL LICENSE AGREEMENT FOR DEVELOPMENT AND COMMERCIALIZATION OF NOVEL BTK INHIBITOR PROGRAM FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES

BRIEF-Jiangsu Hengrui Medicine passes U.S. FDA approval

* Says it received FDA approval for Dexmedetomidine Hydrochloride Injection from U.S. Food and Drug Administration

BRIEF-Jiangsu Hengrui Medicine gets approval for clinical trials of drugs

* Says it gets clinical trials approval for its drug named Seebri® Breezhaler® from China Food and Drug Administration

BRIEF-Jiangsu Hengrui Medicine's 9-month net profit up 20.7 pct y/y

* Says 9-month net profit up 20.7 percent y/y at 2.3 billion yuan ($347.33 million)

BRIEF-Jiangsu Hengrui Medicine passes FDA approval

* Says it received approval for its cisatracurium besilate injection from U.S Food and Drug Administration

BRIEF-Jiangsu Hengrui Medicine's H1 net profit up 19.7 pct y/y

* Says H1 net profit up 19.7 percent y/y at 1.6 billion yuan ($242.26 million)

Select another date: